Marker Therapeutics
MRKR
Marker Therapeutics (MRKR) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Initiated Coverage | Buy | $10.00 | Dec 8, 2025 |
| WBB Securities | Maintained | Strong Buy | $12.50 | Apr 1, 2025 |
| Canaccord Genuity | Initiated Coverage | Buy | $8.00 | Mar 5, 2025 |
| Ladenburg Thalmann | Maintained | Buy | $19.00 from $11.00 | Oct 21, 2024 |
| Ladenburg Thalmann | Initiated Coverage | Buy | $11.00 | Apr 30, 2024 |
Frequently asked questions
What is the latest analyst rating on MRKR?
On Dec 8, 2025, HC Wainwright & Co. initiated coverage of Marker Therapeutics at Buy with a price target of $10.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.